Cytosolic PINK1 orchestrates protein translation during proteasomal stress by phosphorylating the translation elongation factor eEF1A1

FEBS Lett. 2021 Feb;595(4):507-520. doi: 10.1002/1873-3468.14030. Epub 2021 Jan 6.

Abstract

Mutations in PINK1 (PTEN-induced putative kinase 1) are associated with autosomal recessive early-onset Parkinson's disease. Full-length PINK1 (PINK1-l) has been extensively studied in mitophagy; however, the functions of the short form of PINK1 (PINK1-s) remain poorly understood. Here, we report that PINK1-s is recruited to ribosome fractions after short-term inhibition of proteasomes. The expression of PINK1-s greatly inhibits protein synthesis even without proteasomal stress. Mechanistically, PINK1-s phosphorylates the translation elongation factor eEF1A1 during proteasome inhibition. The expression of the phosphorylation mimic mutation eEF1A1S396E rescues protein synthesis defects and cell viability caused by PINK1 knockout. These findings implicate an important role for PINK1-s in protecting cells against proteasome stress through inhibiting protein synthesis.

Keywords: PINK1; Phosphorylation; Proteasome inhibition; Protein synthesis; Stress response; eEF1A1.

MeSH terms

  • Amino Acid Sequence
  • Anisomycin / pharmacology
  • Cell Line
  • Cell Survival / drug effects
  • Cysteine Proteinase Inhibitors / pharmacology
  • Epithelial Cells
  • HEK293 Cells
  • Humans
  • Leupeptins / pharmacology
  • Peptide Elongation Factor 1 / genetics*
  • Peptide Elongation Factor 1 / metabolism
  • Phosphorylation / drug effects
  • Proteasome Endopeptidase Complex / drug effects*
  • Proteasome Endopeptidase Complex / metabolism
  • Protein Biosynthesis / drug effects*
  • Protein Kinases / genetics*
  • Protein Kinases / metabolism
  • Protein Processing, Post-Translational*
  • Protein Synthesis Inhibitors / pharmacology
  • Proteolysis / drug effects
  • RNA, Small Interfering / genetics
  • RNA, Small Interfering / metabolism
  • Ribosomes / drug effects
  • Ribosomes / genetics
  • Ribosomes / metabolism

Substances

  • Cysteine Proteinase Inhibitors
  • EEF1A1 protein, human
  • Leupeptins
  • Peptide Elongation Factor 1
  • Protein Synthesis Inhibitors
  • RNA, Small Interfering
  • Anisomycin
  • Protein Kinases
  • PTEN-induced putative kinase
  • Proteasome Endopeptidase Complex
  • benzyloxycarbonylleucyl-leucyl-leucine aldehyde